- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2010
- Public Summary Document (PSD) November 2010 PBAC Meeting - PDF
Rituximab – November 2010
Rituximab, solution for I.V infusion, 100 mg in 10 mL, 500 mg in 50 mL, MabThera®
Last updated
3 March 2011
